← Back to All Filings

Pelthos (PTHS) Director Gifts 9,542 Shares in Trust Transfer

Low SignificanceDecember 12, 2025 at 5:02:16 PM EST

Pelthos Therapeutics Inc.

$PTHS4CIK: 0001919246

Subscribe to track PTHS

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Pelthos (PTHS) Director Gifts 9,542 Shares in Trust Transfer

Company: Pelthos Therapeutics Inc. (PTHS) Form: 4 | Filed: 2025-12-12 Significance: Low

Insider: Pauls Matthew Title: null | Relationship: Director

Transaction: • Type: Gift • Shares: 9,542 • Price: $0.00 • Value: $0 • Owned After: 1,074

Key Insight: A director transferred 9,542 shares, representing nearly 90% of their direct holdings, to a trust for no consideration. This is typically done for estate planning and is not an open-market sale, carrying low trading significance.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Pelthos Therapeutics Inc. (PTHS)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director made a non-market gift of 9,542 shares, nearly 90% of their direct holdings, to a trust, a move often associated with estate planning rather than a change in market sentiment.
  • Market Impact: Neutral. Gifts are not open-market transactions and typically do not directly influence market price.

Company Information

FieldValue
CompanyPelthos Therapeutics Inc.
Ticker SymbolPTHS
CIK0001919246
IndustryBIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

FieldValue
NamePauls Matthew
CIK0001573429
Title/Positionnull
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2025-12-10
Transaction CodeG (Gift)
Security TypeCommon Stock
Shares Involved9,542
Price Per Share$0.00
Total Value$0
Shares Owned After1,074
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.0%
Shares Transacted9,542
% of Shares OutstandingNot Available
Post-Transaction Ownership1,074 shares (Ownership % Not Available)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction has a reported value of $0, making it immaterial relative to the company's $100 million market capitalization.
  • Ownership Concentration: The director transferred a substantial portion (approximately 89.9%) of their direct holdings. However, as it was a gift to a trust where the insider disclaims beneficial ownership, it does not signal a loss of faith in the company in the same way a market sale would.
  • Dilution Impact: Not applicable, as this was a transfer of existing shares, not an issuance of new equity.
  • Transaction Significance: The significance is low due to the transaction being a gift with a $0 value. Such transfers are common for personal financial and estate planning purposes and are not considered market signals.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: A gift of shares is a non-market event and does not reflect an insider's decision to sell at prevailing market prices. Therefore, it is not expected to impact stock performance.

Volume & Sentiment

  • Expected Volume Impact: None. The transaction occurred off-market and will not register in trading volume.
  • Sentiment Indicator: Neutral. The filing is informational regarding a change in the form of ownership and does not provide a bullish or bearish signal.

Additional Context

Transaction Notes

  • Special Circumstances: Per Footnote 2, the shares were transferred to the 'GP 2024 Trust'. The reporting person is not a trustee, does not retain control over the shares, and disclaims beneficial ownership post-transfer. This confirms the nature of the transaction as a complete disposition for estate planning or similar purposes.
Topics:#SECFiling#InsiderTrading#PTHS#PelthosTherapeutics#Form4#InsiderGift#StockMarket#Investing#FinancialAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.